Back

Quercetin reduces residual dysglycemia in postmenopausal women with established coronary artery disease: a randomized double-blind trial.

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in women: artificial intelligence and coronary artery disease Cardiovascular Disease in Women ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Nathalia Faria

Heart Institute (InCor) HCFMUSP, Sao Paulo (Brazil)

6 More presentations in this session

Presentation thumbnail
Artificial intelligence–based assessment of breast arterial calcification on screening mammography and cardiovascular outcomes: a meta-analysis
Doctor M. Malik (Boston, US)
Abstract Slides Video
Presentation thumbnail
Sex differences in the association between systolic blood pressure control and clinical outcomes in working-age adults
Doctor K. Takegawa (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Cardiovascular risk screening during mammography: high acceptability and potential equity gains
Doctor L. Houston (Sydney, AU)
Abstract Slides Video
Presentation thumbnail
Effects of phytoestrogen supplementation on hormones in postmenopausal women: a systematic review and meta-analysis
Miss N. Faria (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Plasma metabolome reveals systemic oxidative stress and impaired mitochondrial energetics in coronary microvascular dysfunction
Doctor P. Mehta (Atlanta, US)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in women: artificial intelligence and coronary artery disease

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardioprotective effects of the flavonoid quercetin against doxorubicin-Induced cardiotoxicity in H9c2 cardiomyoblasts
20 June 2025
thumbnail
Congress Presentation
High levels of small dense LDL cholesterol potentiate the risk of poor glycemic management for long-term prognosis in patients with stable coronary artery disease
1 September 2025
thumbnail
Congress Presentation
Ultra-processed food reduction in cardiac rehabilitation: a novel complementary pathway to enhance diet quality and cardiometabolic health
23 April 2026
thumbnail
Congress Presentation
First-degree relatives of type-2 diabetic patients and dysglycaemic patients have impaired endothelial function due to decreased bioavailability of nitric oxide
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources